Furthermore, to confirm whether the inhibition of MM progression in LILRB1-KD MM-bearing mice was dependent on ferroptosis induced by the deficiency of LILRB1, we treated luciferase-expressing CTR-KD or LILRB1-KD ARP-1-bearing mice with ferroptosis inhibitor liproxstatin-165. The gene discussed is LILRB1; the disease is Miyoshi myopathy.